These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 8120277)
21. Comparative in vitro studies on the immunosuppressive activities of mycophenolic acid, bredinin, FK 506, cyclosporine, and rapamycin. Zeevi A; Woan M; Yao GZ; Venkataramanan R; Todo S; Starzl TE; Duquesnoy RJ Transplant Proc; 1991 Dec; 23(6):2928-30. PubMed ID: 1721315 [No Abstract] [Full Text] [Related]
22. The hydroxylamine of sulfamethoxazole synergizes with FK506 and cyclosporin A, inhibiting T-cell proliferation. Hess DA; Bird IA; Almawi WY; Rieder MJ J Pharmacol Exp Ther; 1997 Apr; 281(1):540-8. PubMed ID: 9103542 [TBL] [Abstract][Full Text] [Related]
23. Modulation of glucocorticoid inhibitory action on human lymphocyte mitogenesis: dependence on mitogen concentration and T-cell maturity. Ranelletti FO; Musiani P; Maggiano N; Lauriola L; Piantelli M Cell Immunol; 1983 Feb; 76(1):22-8. PubMed ID: 6600979 [TBL] [Abstract][Full Text] [Related]
24. Anti-CD28 antibody- and IL-4-induced human T cell proliferation is sensitive to rapamycin. Luo H; Chen H; Daloze P; St-Louis G; Wu J Clin Exp Immunol; 1993 Nov; 94(2):371-6. PubMed ID: 8222329 [TBL] [Abstract][Full Text] [Related]
25. Effect of rapamycin on the in vitro release of soluble interleukin-2 receptor by phytohemagglutinin, phorbol myristate acetate, and ionomycin-activated peripheral blood mononuclear cells. Barkis I; Hadjiyannaki-Koniavitou K; Vareltzides A; Hornung N; Raskova J; Degiannis D Transplant Proc; 1995 Feb; 27(1):432-4. PubMed ID: 7879050 [No Abstract] [Full Text] [Related]
26. Effect of rapamycin on the cyclosporin A-resistant CD28-mediated costimulatory pathway. Ghosh P; Buchholz MA; Yano S; Taub D; Longo DL Blood; 2002 Jun; 99(12):4517-24. PubMed ID: 12036883 [TBL] [Abstract][Full Text] [Related]
27. Modes of action of FK506, cyclosporin A, and rapamycin. Morris R Transplant Proc; 1994 Dec; 26(6):3272-5. PubMed ID: 7527964 [No Abstract] [Full Text] [Related]
28. Dexamethasone-mediated inhibition of human T cell growth factor and gamma-interferon messenger RNA. Arya SK; Wong-Staal F; Gallo RC J Immunol; 1984 Jul; 133(1):273-6. PubMed ID: 6427338 [TBL] [Abstract][Full Text] [Related]
29. Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. Kam JC; Szefler SJ; Surs W; Sher ER; Leung DY J Immunol; 1993 Oct; 151(7):3460-6. PubMed ID: 8376786 [TBL] [Abstract][Full Text] [Related]
30. Cyclosporine A reduces T lymphocyte activity and improves airway hyperresponsiveness in corticosteroid-dependent chronic severe asthma. Fukuda T; Asakawa J; Motojima S; Makino S Ann Allergy Asthma Immunol; 1995 Jul; 75(1):65-72. PubMed ID: 7621064 [TBL] [Abstract][Full Text] [Related]
31. Differences in dexamethasone-sensitivity between lymphocytes from patients with Alzheimer's disease and patients with multi-infarct dementia. Nijhuis EW; Oostervink F; Hinloopen B; Rozing J; Nagelkerken L Brain Behav Immun; 1996 Jun; 10(2):115-25. PubMed ID: 8811935 [TBL] [Abstract][Full Text] [Related]
32. Glucocorticoids inhibit human antigen-specific and enhance total IgE and IgG4 production due to differential effects on T and B cells in vitro. Akdis CA; Blesken T; Akdis M; Alkan SS; Heusser CH; Blaser K Eur J Immunol; 1997 Sep; 27(9):2351-7. PubMed ID: 9341780 [TBL] [Abstract][Full Text] [Related]
34. Glucocorticoid receptor isoforms in steroid-dependent asthma. Jakieła B; Bochenek G; Sanak M Pol Arch Med Wewn; 2010 Jun; 120(6):214-22. PubMed ID: 20567205 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of the influence of FK 506, rapamycin, and cyclosporine on processing and presentation of particulate antigen by macrophages: assessment of a drug "carry-over" effect. Cooper MH; Gregory SH; Thomson AW; Fung JJ; Starzl TE; Wing EJ Transplant Proc; 1991 Dec; 23(6):2957-8. PubMed ID: 1721326 [No Abstract] [Full Text] [Related]
36. Glucocorticoid inhibitory action on the response to PHA of residual circulatory lymphocytes in renal transplant patients following immunosuppressive therapy. Musiani P; Citterio F; Maggiano N; Pozzetto U; Lauriola L; Luciani G; Ranelletti FO; Castagneto M; Piantelli M Clin Exp Immunol; 1984 Jan; 55(1):217-23. PubMed ID: 6362935 [TBL] [Abstract][Full Text] [Related]
37. The synergistic interactions in vitro and in vivo of brequinar sodium with cyclosporine or rapamycin alone and in triple combination. Kahan BD; Tejpal N; Gibbons-Stubbers S; Tu Y; Wang M; Stepkowski S; Chou TC Transplantation; 1993 Apr; 55(4):894-900. PubMed ID: 8475566 [TBL] [Abstract][Full Text] [Related]
38. Differential inhibition of cutaneous T-cell-mediated reactions and epidermal cell proliferation by cyclosporin A, FK-506, and rapamycin. Duncan JI J Invest Dermatol; 1994 Jan; 102(1):84-8. PubMed ID: 7507155 [TBL] [Abstract][Full Text] [Related]
39. Direct inhibition of human CD8+ lymphocyte activation by cyclosporine A and Rapamune-Sirolimus. Combates NJ; Degiannis D; Raskova J; Raska K Clin Immunol Immunopathol; 1995 Dec; 77(3):221-8. PubMed ID: 7586731 [TBL] [Abstract][Full Text] [Related]
40. Evidence that rapamycin inhibits interleukin-12-induced proliferation of activated T lymphocytes. Bertagnolli MM; Yang L; Herrmann SH; Kirkman RL Transplantation; 1994 Nov; 58(10):1091-6. PubMed ID: 7974715 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]